BEAM
Beam Therapeutics Inc.$31.00+0.13 (+0.42%)Prev Close$30.89·MCap$3.36B·P/E—·Vol1.07M·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
23
$21.58M
◆
Net Activity
Net Seller
$21.58M
●
Active Insiders
7
last 12 mo
Over the past 12 months, insider activity at Beam Therapeutics Inc. (BEAM) has been exclusively selling, with 0 insider purchases totaling $0.00 and 23 insider sales totaling $21.58M. The most recent insider transaction was by Simon Amy (officer: Chief Medical Officer), who sold $13.0K worth of shares on Jul 2, 2026. Beam Therapeutics Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $3.36B.
BEAM Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jul 2, 2026 | Simon Amy | officer: Chief Medical Officer | Sell | 373 | $34.73 | $13.0K | 102,363 |
| Jul 1, 2026 | Evans John M. | director, officer: CEO | Sell | 50,000 | $34.90 | $1.75M | 1,058,784 |
| Jun 29, 2026 | FMR LLC | 10 percent owner, other: See Remark 1 | Sell | 284,860 | $35.24 | $10.04M | 1,106,071 |
| Apr 6, 2026 | Evans John M. | director, officer: CEO | Sell | 30,078 | $24.58 | $739.3K | 1,047,205 |
| Apr 6, 2026 | Bellon Christine | officer: Chief Legal Officer | Sell | 5,956 | $24.58 | $146.4K | 109,711 |
| Apr 6, 2026 | Simon Amy | officer: Chief Medical Officer | Sell | 6,700 | $24.58 | $164.7K | 102,735 |
| Apr 6, 2026 | Cavanagh Bethany J | officer: SVP, Finance and Treasurer | Sell | 3,242 | $24.58 | $79.7K | 51,171 |
| Apr 6, 2026 | Ciaramella Giuseppe | officer: President | Sell | 11,810 | $24.58 | $290.3K | 218,406 |
| Apr 1, 2026 | Evans John M. | director, officer: CEO | Sell | 50,000 | $22.57 | $1.13M | 986,667 |
| Feb 26, 2026 | Ciaramella Giuseppe | officer: President | Sell | 35,000 | $32.00 | $1.12M | 190,216 |
| Feb 2, 2026 | Evans John M. | director, officer: CEO | Sell | 47,094 | $28.86 | $1.36M | 995,334 |
| Jan 29, 2026 | Evans John M. | CEO | Sell | 50,000 | $28.87 | $1.44M | 0 |
| Jan 26, 2026 | Bellon Christine | officer: Chief Legal Officer | Sell | 1,371 | $34.00 | $46.6K | 95,667 |
| Jan 26, 2026 | Cavanagh Bethany J | officer: SVP, Finance and Treasurer | Sell | 6,198 | $35.00 | $216.9K | 34,813 |
| Jan 22, 2026 | Cavanagh Bethany J | SVP, Finance and Treasurer | Sell | 6,198 | $35.00 | $216.9K | 0 |
| Jan 20, 2026 | Bellon Christine | officer: Chief Legal Officer | Sell | 18,629 | $34.61 | $644.8K | 113,556 |
| Jan 20, 2026 | Cavanagh Bethany J | SVP, Finance and Treasurer | Sell | 3,034 | $30.12 | $91.4K | 0 |
| Jan 15, 2026 | Bellon Christine | Chief Legal Officer | Sell | 18,629 | $34.61 | $644.8K | 0 |
| Dec 31, 2025 | Bellon Christine | Chief Legal Officer | Sell | 1,254 | $27.10 | $34.0K | 0 |
| Dec 31, 2025 | Emany Sravan Kumar | Chief Financial Officer | Sell | 6,294 | $27.10 | $170.6K | 0 |
| Oct 1, 2025 | Bellon Christine | Chief Legal Officer | Sell | 373 | $24.53 | $9.1K | 0 |
| Oct 1, 2025 | Cavanagh Bethany J | SVP, Finance and Treasurer | Sell | 467 | $24.53 | $11.5K | 0 |
| Oct 1, 2025 | Evans John M. | CEO | Sell | 50,000 | $24.57 | $1.23M | 0 |
| Jul 1, 2025 | Simon Amy | Chief Medical Officer | Sell | 1,250 | $19.17 | $24.0K | 0 |
| Apr 1, 2025 | Bellon Christine | Chief Legal Officer | Sell | 5,674 | $18.35 | $104.1K | 0 |
| Apr 1, 2025 | Cavanagh Bethany J | SVP, Finance and Treasurer | Sell | 3,015 | $18.35 | $55.3K | 0 |
| Apr 1, 2025 | Ciaramella Giuseppe | President | Sell | 7,434 | $18.35 | $136.4K | 0 |
| Apr 1, 2025 | Evans John M. | CEO | Sell | 30,663 | $18.35 | $562.7K | 0 |
| Apr 1, 2025 | Simon Amy | Chief Medical Officer | Sell | 30,563 | $17.92 | $547.8K | 0 |
| Feb 18, 2025 | Cavanagh Bethany J | SVP, Finance and Treasurer | Sell | 6,287 | $35.00 | $220.0K | 0 |
| Feb 14, 2025 | Bellon Christine | Chief Legal Officer | Sell | 10,000 | $34.00 | $340.0K | 0 |
| Jan 30, 2025 | Evans John M. | CEO | Sell | 30,000 | $26.75 | $802.5K | 0 |
| Jan 2, 2025 | Bellon Christine | Chief Legal Officer | Sell | 1,241 | $24.68 | $30.6K | 0 |
| Jan 2, 2025 | Cavanagh Bethany J | SVP, Finance and Treasurer | Sell | 1,117 | $24.68 | $27.6K | 0 |
| Nov 6, 2024 | Ciaramella Giuseppe | President | Sell | 51,110 | $26.36 | $1.35M | 0 |
| Oct 14, 2024 | Ciaramella Giuseppe | President | Sell | 51,110 | $26.27 | $1.34M | 0 |
| Oct 1, 2024 | Bellon Christine | Chief Legal Officer | Sell | 385 | $23.48 | $9.0K | 0 |
| Sep 30, 2024 | Cavanagh Bethany J | SVP, Finance and Treasurer | Sell | 289 | $23.48 | $6.8K | 0 |
| Sep 30, 2024 | Evans John M. | CEO | Sell | 60,000 | $24.60 | $1.48M | 0 |
| Jul 1, 2024 | Simon Amy | Chief Medical Officer | Sell | 1,250 | $23.28 | $29.1K | 0 |
| Jun 27, 2024 | Evans John M. | CEO | Sell | 60,000 | $24.50 | $1.47M | 0 |
| Apr 1, 2024 | Bellon Christine | Chief Legal Officer | Sell | 3,401 | $32.12 | $109.2K | 0 |
| Apr 1, 2024 | Burrell Terry-Ann | Chief Financial Officer | Sell | 5,446 | $32.12 | $174.9K | 0 |
| Apr 1, 2024 | Ciaramella Giuseppe | President | Sell | 4,534 | $32.12 | $145.6K | 0 |
| Apr 1, 2024 | Evans John M. | CEO | Sell | 18,102 | $32.13 | $581.6K | 0 |
| Apr 1, 2024 | Simon Amy | Chief Medical Officer | Sell | 23,687 | $31.02 | $734.8K | 0 |
| Mar 28, 2024 | Evans John M. | CEO | Sell | 60,000 | $33.86 | $2.03M | 0 |
| Jan 31, 2024 | Evans John M. | CEO | Sell | 60,000 | $25.33 | $1.52M | 0 |
| Jan 3, 2024 | Bellon Christine | Chief Legal Officer | Sell | 1,907 | $26.42 | $50.4K | 0 |
| Nov 20, 2023 | Bellon Christine | Chief Legal Officer | Sell | 10,000 | $30.50 | $305.0K | 0 |
Showing 1–50 of 81
1 / 2
BEAM Insider Buying Activity
The following table shows recent insider purchases of Beam Therapeutics Inc. (BEAM) stock reported via SEC Form 4 filings.
No insider buying activity found for BEAM in the last 12 months.
BEAM Insider Selling Activity
The following table shows recent insider sales of Beam Therapeutics Inc. (BEAM) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jul 2, 2026 | Simon Amy | officer: Chief Medical Officer | Sell | 373 | $34.73 | $13.0K | 102,363 |
| Jul 1, 2026 | Evans John M. | director, officer: CEO | Sell | 50,000 | $34.90 | $1.75M | 1,058,784 |
| Jun 29, 2026 | FMR LLC | 10 percent owner, other: See Remark 1 | Sell | 284,860 | $35.24 | $10.04M | 1,106,071 |
| Apr 6, 2026 | Evans John M. | director, officer: CEO | Sell | 30,078 | $24.58 | $739.3K | 1,047,205 |
| Apr 6, 2026 | Bellon Christine | officer: Chief Legal Officer | Sell | 5,956 | $24.58 | $146.4K | 109,711 |
| Apr 6, 2026 | Simon Amy | officer: Chief Medical Officer | Sell | 6,700 | $24.58 | $164.7K | 102,735 |
| Apr 6, 2026 | Cavanagh Bethany J | officer: SVP, Finance and Treasurer | Sell | 3,242 | $24.58 | $79.7K | 51,171 |
| Apr 6, 2026 | Ciaramella Giuseppe | officer: President | Sell | 11,810 | $24.58 | $290.3K | 218,406 |
| Apr 1, 2026 | Evans John M. | director, officer: CEO | Sell | 50,000 | $22.57 | $1.13M | 986,667 |
| Feb 26, 2026 | Ciaramella Giuseppe | officer: President | Sell | 35,000 | $32.00 | $1.12M | 190,216 |
| Feb 2, 2026 | Evans John M. | director, officer: CEO | Sell | 47,094 | $28.86 | $1.36M | 995,334 |
| Jan 29, 2026 | Evans John M. | CEO | Sell | 50,000 | $28.87 | $1.44M | 0 |
| Jan 26, 2026 | Bellon Christine | officer: Chief Legal Officer | Sell | 1,371 | $34.00 | $46.6K | 95,667 |
| Jan 26, 2026 | Cavanagh Bethany J | officer: SVP, Finance and Treasurer | Sell | 6,198 | $35.00 | $216.9K | 34,813 |
| Jan 22, 2026 | Cavanagh Bethany J | SVP, Finance and Treasurer | Sell | 6,198 | $35.00 | $216.9K | 0 |
| Jan 20, 2026 | Bellon Christine | officer: Chief Legal Officer | Sell | 18,629 | $34.61 | $644.8K | 113,556 |
| Jan 20, 2026 | Cavanagh Bethany J | SVP, Finance and Treasurer | Sell | 3,034 | $30.12 | $91.4K | 0 |
| Jan 15, 2026 | Bellon Christine | Chief Legal Officer | Sell | 18,629 | $34.61 | $644.8K | 0 |
| Dec 31, 2025 | Bellon Christine | Chief Legal Officer | Sell | 1,254 | $27.10 | $34.0K | 0 |
| Dec 31, 2025 | Emany Sravan Kumar | Chief Financial Officer | Sell | 6,294 | $27.10 | $170.6K | 0 |
| Oct 1, 2025 | Bellon Christine | Chief Legal Officer | Sell | 373 | $24.53 | $9.1K | 0 |
| Oct 1, 2025 | Cavanagh Bethany J | SVP, Finance and Treasurer | Sell | 467 | $24.53 | $11.5K | 0 |
| Oct 1, 2025 | Evans John M. | CEO | Sell | 50,000 | $24.57 | $1.23M | 0 |
| Jul 1, 2025 | Simon Amy | Chief Medical Officer | Sell | 1,250 | $19.17 | $24.0K | 0 |
| Apr 1, 2025 | Bellon Christine | Chief Legal Officer | Sell | 5,674 | $18.35 | $104.1K | 0 |
| Apr 1, 2025 | Cavanagh Bethany J | SVP, Finance and Treasurer | Sell | 3,015 | $18.35 | $55.3K | 0 |
| Apr 1, 2025 | Ciaramella Giuseppe | President | Sell | 7,434 | $18.35 | $136.4K | 0 |
| Apr 1, 2025 | Evans John M. | CEO | Sell | 30,663 | $18.35 | $562.7K | 0 |
| Apr 1, 2025 | Simon Amy | Chief Medical Officer | Sell | 30,563 | $17.92 | $547.8K | 0 |
| Feb 18, 2025 | Cavanagh Bethany J | SVP, Finance and Treasurer | Sell | 6,287 | $35.00 | $220.0K | 0 |
| Feb 14, 2025 | Bellon Christine | Chief Legal Officer | Sell | 10,000 | $34.00 | $340.0K | 0 |
| Jan 30, 2025 | Evans John M. | CEO | Sell | 30,000 | $26.75 | $802.5K | 0 |
| Jan 2, 2025 | Bellon Christine | Chief Legal Officer | Sell | 1,241 | $24.68 | $30.6K | 0 |
| Jan 2, 2025 | Cavanagh Bethany J | SVP, Finance and Treasurer | Sell | 1,117 | $24.68 | $27.6K | 0 |
| Nov 6, 2024 | Ciaramella Giuseppe | President | Sell | 51,110 | $26.36 | $1.35M | 0 |
| Oct 14, 2024 | Ciaramella Giuseppe | President | Sell | 51,110 | $26.27 | $1.34M | 0 |
| Oct 1, 2024 | Bellon Christine | Chief Legal Officer | Sell | 385 | $23.48 | $9.0K | 0 |
| Sep 30, 2024 | Cavanagh Bethany J | SVP, Finance and Treasurer | Sell | 289 | $23.48 | $6.8K | 0 |
| Sep 30, 2024 | Evans John M. | CEO | Sell | 60,000 | $24.60 | $1.48M | 0 |
| Jul 1, 2024 | Simon Amy | Chief Medical Officer | Sell | 1,250 | $23.28 | $29.1K | 0 |
| Jun 27, 2024 | Evans John M. | CEO | Sell | 60,000 | $24.50 | $1.47M | 0 |
| Apr 1, 2024 | Bellon Christine | Chief Legal Officer | Sell | 3,401 | $32.12 | $109.2K | 0 |
| Apr 1, 2024 | Burrell Terry-Ann | Chief Financial Officer | Sell | 5,446 | $32.12 | $174.9K | 0 |
| Apr 1, 2024 | Ciaramella Giuseppe | President | Sell | 4,534 | $32.12 | $145.6K | 0 |
| Apr 1, 2024 | Evans John M. | CEO | Sell | 18,102 | $32.13 | $581.6K | 0 |
| Apr 1, 2024 | Simon Amy | Chief Medical Officer | Sell | 23,687 | $31.02 | $734.8K | 0 |
| Mar 28, 2024 | Evans John M. | CEO | Sell | 60,000 | $33.86 | $2.03M | 0 |
| Jan 31, 2024 | Evans John M. | CEO | Sell | 60,000 | $25.33 | $1.52M | 0 |
| Jan 3, 2024 | Bellon Christine | Chief Legal Officer | Sell | 1,907 | $26.42 | $50.4K | 0 |
| Nov 20, 2023 | Bellon Christine | Chief Legal Officer | Sell | 10,000 | $30.50 | $305.0K | 0 |
BEAM Insiders
Similar Stocks to BEAM
VRTX
Vertex Pharmaceuticals Incorporated
$476.29+0.08%
$126.50B
REGN
Regeneron Pharmaceuticals, Inc.
$662.73+1.01%
$68.29B
ALNY
Alnylam Pharmaceuticals, Inc.
$275.93-1.72%
$43.19B
RVMD
Revolution Medicines, Inc.
$185.71+0.42%
$40.34B
MRNA
Moderna, Inc.
$68.11+1.00%
$27.09B
INSM
Insmed Incorporated
$109.25-0.67%
$25.06B
INCY
Incyte Corporation
$114.43-0.30%
$23.32B
UTHR
United Therapeutics Corporation
$530.63+0.75%
$23.22B